Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect

scientific article published on July 1996

Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/TX950216S
P698PubMed publication ID8828922
P5875ResearchGate publication ID14376295

P2093author name stringNau H
Elmazar MM
Bojic U
Hauck RS
P433issue5
P921main subjectteratogenicityQ56246640
P304page(s)866-870
P577publication date1996-07-01
P1433published inChemical Research in ToxicologyQ473530
P1476titleFurther branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect
P478volume9

Reverse relations

cites work (P2860)
Q40189817A Flavin Analogue with Improved Solubility in Organic Solvents.
Q36789953Anticonvulsant efficacy of valproate-like carboxylic acids: a potential target for anti-bipolar therapy
Q53451403Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide.
Q64985073Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid.
Q47639687Differential prenatal toxicity of one straight-chain and five branched-chain primary alcohols in rats
Q40462745Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core struc
Q24670430Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain
Q42985549Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients
Q34102615Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives
Q36673587Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder
Q38258233QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
Q48335916Radial astrocytes: toxic effects induced by antiepileptic drug in the developing rat hippocampus in vitro
Q28972380Seizure control by ketogenic diet-associated medium chain fatty acids
Q55477468Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre.
Q40504360Synthesis and Pharmacological Evaluation of Novel Benzenesulfonamide Derivatives as Potential Anticonvulsant Agents.
Q53612497Synthesis and anticonvulsant activity of ethyl 2,2-dimethyl-1-(2-substitutedhydrazinecarboxamido) cyclopropanecarboxylate derivatives.
Q43793866Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological tests
Q36053511The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver
Q39608766The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid.
Q39570462The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.
Q74463323Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid
Q39575256Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.